Biochimica et Biophysica Acta (BBA) - General Subjects
Reduced glycerol incorporation into phospholipids contributes to impaired intra-erythrocytic growth of glycerol kinase knockout Plasmodium falciparum parasites
Introduction
Malaria is the most deadly vector-borne disease in the world. The World Health Organization estimated that in 2010, Plasmodium parasites were responsible for 216 million cases of infections and approximately 665,000 deaths in 106 malaria-endemic countries [1]. The main cause of morbidity and mortality is Plasmodium falciparum, which is the most lethal of the five parasite species infecting humans. The negative socio-economic impact of the disease, the lack of an effective malaria vaccine, parasite resistance to current anti-malaria drugs and vector resistance to insecticides emphasize the need to identify novel drug targets and develop alternative treatment strategies to combat the disease.
The life cycle of P. falciparum parasites is complex and involves an asexual developmental stage in the human host and a sexual developmental stage in the mosquito vector. Malaria is transmitted through injection of sporozoites from an infected female Anopheles mosquito into the bloodstream of the human host during a blood meal. Sporozoites rapidly migrate to and invade hepatocytes, where they develop to produce tens of thousands of merozoites. These are released into the bloodstream where they invade erythrocytes and during the 48-hour intra-erythrocytic development and replication cycle, a single parasite can produce 16–32 daughter merozoites that subsequently invade other erythrocytes. It is this stage that is responsible for the pathogenesis of malaria [2]. A small proportion of parasites differentiate into male and female gametocytes. These sexual parasites are transmitted to the mosquito during feeding and are essential in ensuring the continued survival of the parasite. Within the mosquito midgut, gamete formation and fertilization take place, followed by the development of thousands of sporozoites within an oocyst and the migration of these sporozoites to the salivary glands completing the Plasmodium life cycle [3].
The extensive proliferation throughout the parasite lifecycle requires a significant increase in lipids, particularly phospholipids (PLs), for successful growth and development of the parasite. Plasmodium-infected red cells contain significantly increased amounts of lipids compared to uninfected erythrocytes. In uninfected red cells, PLs and cholesterol are the major components of red cell membranes, co-existing at a molar ratio of approximately 1.0 [4]. Phosphatidylcholine (30–40%), phosphatidylethanolamine (30–35%), sphingomyelin (15%) and phosphatidylserine (10–20%) are the main PLs. Other phospholipids, such as phosphatidylinositol, phosphatidic acid, cardiolipin and lyso-PLs account for less than 5% of the total PLs, and neutral lipids and fatty acids are scarcely detectable [4]. Upon P. falciparum infection, a 5–6-fold increase [5] in erythrocyte PL content, specifically phosphatidylcholine, phosphatidylethanolamine and phosphatidylinositol, is observed, although the PL composition of the host erythrocyte membrane is not changed significantly [6]. Parasite membranes contain predominantly phosphatidylcholine (40–50%), phosphatidylethanolamine (35–45%) and phosphatidylinositol (4–11%), with sphingomyelin and phosphatidylserine accounting for < 5% [5]. In marked contrast to erythrocytes, there is hardly any cholesterol in parasite membranes due to the parasite's inability to synthesize sterols [5], [7].
P. falciparum meets the high demand for PL species through synthesis from metabolites produced within the parasite and from host precursors [7]. The polar head groups of PLs, as well as fatty acids, are taken up from the host serum, although parasites have the capacity for de novo type II fatty acid synthesis [8].
The parasite's requirement for PLs during growth and development implies that the enzymes, proteins and transporters involved in lipid metabolism may be attractive drug target candidates [9]. Enzymes involved in the Kennedy pathways, for example, are refractory to genetic disruption in Plasmodium berghei [10] and may be essential in blood-stage development of this rodent parasite. Disruption of the P. falciparum phosphoethanolamine methyl transferase in the serine decarboxylation phosphoethanolamine methylation pathway reduced parasite growth rates and lead to increased cell death [11]. Choline analogs have also been shown to inhibit P. falciparum and Plasmodium vivax parasite development in vitro and clear P. falciparum and Plasmodium cynomolgi parasites from infected monkeys [12].
All PLs have a glycerol backbone and glycerophospholipid biosynthesis is initiated when two fatty acid molecules are transferred from a donor to glycerol-3-phosphate (G3P), an important metabolite at the interface of carbohydrate and lipid metabolism. In P. falciparum, G3P is thought to be produced primarily from the glycolytic intermediate, dihydroxyacetone phosphate [13], since glucose consumption is increased up to 100-fold in parasitized red blood cells (RBCs) [14]. However, an alternative route exists whereby glycerol is taken up from the host erythrocyte [15] and incorporated into PLs as shown by metabolic labeling studies in Plasmodium knowlesi [16]. Phosphorylation of glycerol to produce G3P is catalyzed by glycerol kinase (GK), a highly conserved enzyme. The P. falciparum GK orthologue (PfGK, PlasmoDB gene ID PF3D7_1351600) has approximately 50% amino acid similarity to both human and Escherichia coli enzymes [17]. It has been expressed in vitro [17] and crystallized [18]. Interestingly, despite mRNA expression throughout parasite development [19], PfGK gene disruption showed that the enzyme appeared to be non-essential in blood stage development [18]. However, the characterization of a P. falciparum aquaglyceroporin (PfAQP) glycerol facilitator [15], [20], the presence of an erythrocyte aquaglyceroporin (hAQP3) [21] and the ability of the parasite to utilize serum glycerol as a precursor for PL synthesis [16] indicate that the role of glycerol during the intra-erythrocytic developmental stage of the parasite should be further investigated.
Section snippets
P. falciparum parasite culture
3D7 P. falciparum parasites were cultured as described by Trager and Jensen [22], with slight modifications. Parasites were maintained in RPMI supplemented with 25 mM HEPES, 2 mM l-Glutamine, 50 mg/L gentamycin, 50 mg/L hypoxanthine and 0.5% Albumax II (Invitrogen, USA). Gametocytes were produced and cultured as described [23]. Cultures were maintained in O+ RBCs at a 5% hematocrit and gassed with a 2% O2, 5% CO2 and 93% N2 gas mixture.
Generation of P. falciparum glycerol kinase knockout parasites (3D7ΔPfGK)
PfGK was disrupted using double-crossover homologous
PfGK is non-essential for intra-erythrocytic development
The gene knockout strategy was performed using double crossover homologous recombination (Fig. 1). A 519 bp 5′ PfGK gene region, representing part of the glycerol-binding domain, was cloned upstream of the hDHFR cassette and a 515 bp 3′ PfGK gene region, representing part of the ADP-binding domain, was cloned downstream of hDHFR. The internal 420 bp PfGK region (nucleotides 545–965, amino acids 181–322) was replaced with the hDHFR cassette and as a result, residues involved in binding glycerol
Discussion
Glycerol plays a fundamental role in several physiological processes and is an important intermediate in energy metabolism. Glucose-deprived bacteria, for example, have a measured growth rate in glycerol of approximately 74% of that achieved on glucose [31] and Saccharomyces cerevisiae can use glycerol as the sole carbon source under aerobic conditions [32]. Human erythrocytes are known to be highly permeable to solutes, including glycerol, which is transported into the cell by an aquaporin
Conclusions
The reduced growth of 3D7ΔPfGK parasites and the incorporation of glycerol into phospholipids imply that P. falciparum utilizes glycerol as an alternative carbon source during asexual development and that it is required for optimal proliferation. The energy requirements of the parasite are at a peak during blood stage development and these are met through glucose metabolism by glycolysis to produce ATP, whereas glycerol is used for phospholipid synthesis and membrane biogenesis. To fully
Acknowledgements
The authors would like to thank Professor Alan F. Cowman for kindly providing the pCC-1 and pCC-1-EBA plasmids and Beckman Coulter South Africa for their generous support with a FC500 Flow Cytometer. We would like to give special thanks to Dr Sonja B. Lauterbach for her technical expertise and advice during this study and to Dewaldt Engelbrecht for his assistance in optimizing the thiazole orange flow cytometry protocol for the P. falciparum growth assays. This work is based upon research
References (49)
- et al.
The journey of the malaria parasite in the mosquito: hopes for the new century
Parasitol. Today
(2000) - et al.
The Kennedy phospholipid biosynthesis pathways are refractory to genetic disruption in Plasmodium berghei and therefore appear essential in blood stages
Mol. Biochem. Parasitol.
(2010) - et al.
Disruption of the Plasmodium falciparum PfPMT gene results in a complete loss of phosphatidylcholine biosynthesis via the serine-decarboxylase-phosphoethanolamine-methyltransferase pathway and severe growth and survival defects
J. Biol. Chem.
(2008) - et al.
Glycerophospholipid acquisition in Plasmodium — a puzzling assembly of biosynthetic pathways
Int. J. Parasitol.
(2010) - et al.
A single, bi-functional aquaglyceroporin in blood-stage Plasmodium falciparum malaria parasites
J. Biol. Chem.
(2002) Incorporation of 14C-labelled non-lipid precursors into lipid of Plasmodium knowlesi in vitro
Comp. Biochem. Physiol. B
(1971)- et al.
Recruitment of human aquaporin 3 to internal membranes in the Plasmodium falciparum infected erythrocyte
Mol. Biochem. Parasitol.
(2009) - et al.
Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination
Mol. Biochem. Parasitol.
(2006) - et al.
Modification of the Dittmer–Lester reagent for the detection of phospholipid derivatives on thin-layer chromatograms
J. Lipid Res.
(1979) Flux analysis and control of the central metabolic pathways in Escherichia coli
FEMS Microbiol. Rev.
(1996)
Osmoregulation and glycerol metabolism in the yeast Saccharomyces cerevisiae
FEMS Microbiol. Rev.
Plasmodium falciparum biology: analysis of in vitro versus in vivo growth conditions
Trends Parasitol.
Glycerol metabolism in severe falciparum malaria
Metabolism
The Plasmodium falciparum sexual development transcriptome: a microarray analysis using ontology-based pattern identification
Mol. Biochem. Parasitol.
Rodent and nonrodent malaria parasites differ in their phospholipid metabolic pathways
J. Lipid Res.
World Malaria Report: 2011
The pathogenic basis of malaria
Nature
Disorders of the red blood cell membrane
Plasmodium lipids: metabolism and function
Malarial lipids
Lipids and the malarial parasite
Bull. World Health Organ.
Genome sequence of the human malaria parasite Plasmodium falciparum
Nature
Targeting the lipid metabolic pathways for the treatment of malaria
Drug Dev. Res.
A class of potent antimalarials and their specific accumulation in infected erythrocytes
Science
Cited by (8)
Creative interior design by Plasmodium falciparum: Lipid metabolism and the parasite's secret chamber
2021, Parasitology InternationalCitation Excerpt :That DGAT is an essential blood stage parasite gene [44] is also supported by a recent transposon-based screening of essential genes [48]. By contrast, knocking out glycerol kinase (GK) did not inhibit asexual parasite growth; instead, parasite growth was only reduced to 56% of the wild-type parasite's growth [49], indicating that the supply of G3P (a product of the GK reaction) from glycolysis can support the Kennedy cycle. Possible imbalances or equilibrium shifts in this cycle may result in the observed reduction in parasite growth.
- 1
Tel.: + 27 11 717 2419; fax: + 27 11 717 2395.